4 related articles for article (PubMed ID: 38768337)
1. EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma.
Landgren O; Prior TJ; Masterson T; Heuck C; Bueno OF; Dash AB; Einsele H; Goldschmidt H; Knop S; Li C; Mellqvist UH; McFadden I; Oprea C; Ross JA; Talpes M; Hydren J; Ahlstrom J; Kazandjian D; Weinhold N; Zhang R; Stetler-Stevenson M; Marti GE; Devlin SM
Blood; 2024 May; ():. PubMed ID: 38768337
[TBL] [Abstract][Full Text] [Related]
2.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
3.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
